Breakthrough PTSD treatment achieves 68% remission rate in clinical trial
ScienceDaily
A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68% remission. Researchers believe the technology could transform…
Summary from ScienceDaily
Coverage
-
ScienceDailyBreakthrough PTSD treatment achieves 68% remission rate in clinical trial
A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68%…
Read on ScienceDaily
